Programs

Optimizing Outcomes in Newly Diagnosed Multiple Myeloma: Integrating Anti-CD38 Monoclonal Antibody Therapy Into Clinical Practice

Did you miss the latest updates on multiple myeloma presented at ASH 2021? Join Dr Faith Davies and Dr Nina Shah as they review late-breaking data on approved and emerging therapies for newly diagnosed multiple myeloma!

https://learning.freecme.com/a/38663PA6uG2J

 

Itching for a CSU Cure: The Shift From Symptom Relief to Curative Therapies – An Older African American Adult Male With Widespread, Persistent Pruritus

Join Chesahna Kindred, MD, MBA, FAAD, and Jonathan A. Bernstein, MD, as they discuss missed opportunities for the management and assessment of chronic spontaneous urticaria (CSU) in this interactive learning experience that uniquely mirrors what you may encounter in clinical practice. The activity will present you with a CSU patient with skin of color and challenge your clinical decision-making skills.

https://realcme.realcme.com/learner/course/2855

 

 

Itching for a CSU Cure: The Shift From Symptom Relief to Curative Therapies – A Caucasian Adult Female With Recurrent, Uncontrolled Angioedema and Urticaria

Join Chesahna Kindred, MD, MBA, FAAD, and Jonathan A. Bernstein, MD, as they discuss missed opportunities for the diagnosis, management, and assessment of chronic spontaneous urticaria (CSU) in this interactive learning experience that uniquely mirrors what you may encounter in clinical practice. The activity will present you with a CSU patient receiving suboptimal care and challenge your clinical decision-making skills.

https://realcme.realcme.com/learner/course/2854